• Our Story

    Galen was founded in Craigavon, Northern Ireland in 1968 by the late Sir Allen McClay (d. 2010), the revered philanthropist and entrepreneur.

    Sir Allen invested in research and innovation, to ensure the latest advances in healthcare would be available to all, and to foster employment opportunities locally. In 1997, Galen became Northern Ireland’s first £1 billion company and in 2002, Sir Allen formed what is now known as the Almac Group.

    Galen is proud member of the Almac Group of world-class companies in the pharmaceutical and biotech sectors. The Group is wholly owned by the McClay Foundation, whose overarching aim is to make a meaningful improvement and advancement in human health.

    We champion the values upon which Galen was built and remain passionate about Sir Allen’s mission to improve and optimise human health, and to achieve a meaningful impact on patients' lives.

  • What we do

    At Galen, we have purpose and passion in everything we do and encourage our people to dare to be extraordinary so we can benefit the health of all generations.

    We are privately owned pharmaceutical company established in 1968, with global headquarters in Craigavon, Northern Ireland, and commercial operations based in the UK, Ireland, the Nordics, Europe, and the USA.

    Galen’s focus is selling medicines worldwide in the areas of pain management, dermatology, and gastroenterology. We are committed to customer care and partner with like-minded companies to accomplish this.

    Through organic growth and acquisitions, we have established product sales in 25 locations. We continue to actively seek new markets and new opportunities, expanding to offer a global reach from our base in Northern Ireland.

    As a proud member of the Almac Group of world-class companies in the pharmaceutical and biotech sectors, we have access to a wide variety of services and expertise, from drug discovery to commercial-scale manufacture.

    By combining innovation in product development with competitive pricing, we work together, in partnership with healthcare professionals and patients to create real, long-term value, a major factor in our success to date.

    Our expertise lies in:

    • sales, marketing and launch excellence
    • market access
    • regulatory affairs, pharmacovigilance and medical affairs
    • supply chain and logistics.

50+

Years of Experience

75 +

Current Products

25

Locations Worldwide


Our Vision & Core Values

Our Vision & Core Values

Our Locations

Global and EU Headquarters

  • Galen Limited
  • 20 Seagoe Industrial Estate
  • Craigavon BT63 5QD
  • United Kingdom
  •  
  • +44(0)28 3833 2200
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Galen Nordics

  • POA Pharma Scandinavia AB
  • Banevænget 13,1
  • 3460 Birkerød
  • Denmark
  • +45 3117 4300
  •  This email address is being protected from spambots. You need JavaScript enabled to view it.

Operations

Dundalk, IE

Galen Pharma Ireland Limited
Finnabair Industrial Estate
Dundalk, Co. Louth
Ireland

Telephone: +353 42 932 0718

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Operations

Sprockhövel, DE

POA Pharma GmbH
Langenbruchstraße 20A
D-45549 Sprockhövel
Germany

Telephone: +49 (0)2339 9113404

Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Operations

Souderton, PA 

Galen US Inc.
25 Fretz Road
Souderton, PA 18964
United States of America

Telephone:  +1(215) 660 8500 

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Would you like to discuss how Galen can help you?

If you would like to explore how our expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.